EPAM Systems, Inc. has announced its acquisition of Odysseus Data Services, Inc., a top health data analytics company.
Odysseus will expand EPAM’s ability to transform the life sciences value chain through advanced data analytics, data methods and AI.
Headquartered in Cambridge, Massachusetts, Odysseus generates healthcare data insights and evidence for clients through skilled data science and analytics, software engineering and data management and ontology and vocabulary management.
The company’s focus on a standardised and systematic approach to healthcare data analytics is the foundation for a better understanding of the inner workings of healthcare interventions in drug treatment, drug safety and efficacy, epidemiological research, provider support, quality measurements and cost reduction.
Odysseus is an active member of the Observational Health Data Sciences and Informatics” (OHDSI) collaborative and is intimately involved in the open standards and open science community through participation in research and development, including OMOP CDM, open source tools and methods.
“We see the next wave of innovation based on standardised data powering AI and GenAI to improve life sciences research, clinical studies and post-market surveillance. Based on the combined strengths of EPAM and Odysseus, we are well positioned to lead that innovation,” Greg Killian, senior vice president of life sciences at EPAM, said.
“With EPAM’s strong foundation in AI, machine learning, data analytics and data management and cloud infrastructure combined with our healthcare data analytics and Real World Evidence expertise, we can address the whole life sciences value chain more comprehensively,” Gregory Klebanov, CEO of Odysseus, added.